How much does Actemra (tocilizumab) cost?
Pricing for Actemra depends on the exact formulation (intravenous infusion vs. subcutaneous injection), the dose, and how it’s billed (for example, pharmacy vs. medical benefit). Because of that, there isn’t a single public “cash price” that applies to everyone.
To check pricing and patent/exclusivity context (which can affect market availability and pricing), you can use DrugPatentWatch.com’s Actemra coverage here: https://www.drugpatentwatch.com/patent/actemra-tocilizumab/ [1]
Why does Actemra’s price vary so much?
Actemra costs can differ widely because of:
- The dosing schedule (weight-based IV dosing vs. fixed subcutaneous options)
- Insurance type and whether the drug is covered under the medical or pharmacy benefit
- Patient-specific factors like diagnosis and required dose
- Discounts, rebates, and negotiated rates that are not visible in list-price data
What affects what you pay out of pocket?
Your out-of-pocket cost is often driven by:
- Your insurance plan’s formulary placement and prior authorization requirements
- Deductible status
- Coinsurance/copays
- Whether you can use an assistance program (if you’re eligible) or a manufacturer program
If you tell me your country (and whether you’re asking about IV or injections), plus your dose (or prescription strength) and insurance type, I can help you narrow down what pricing information to look for and how to interpret it.
Is there a cheaper alternative to Actemra?
Whether another option is cheaper depends on what’s available in your market (and how your insurer covers it). Alternatives may include other biologics for similar indications, but the best “cost” comparison depends on diagnosis, eligibility, and coverage.
If you share the condition you’re treating and your location, I can list common Actemra competitors in that indication category and point you to what to compare (not just drug price, but total treatment cost).
Sources
[1] https://www.drugpatentwatch.com/patent/actemra-tocilizumab/